CD49d blockade by natalizumab in patients with multiple sclerosis affects steady-state hematopoiesis and mobilizes progenitors with a distinct phenotype and function

Jahr

Publikationsjahr
2010

Autoren

Autorenliste der Publikation
Jing D, Oelschlaegel U, Ordemann R, Hölig K, Ehninger G, Reichmann H, Ziemssen T, Bornhäuser M.

Verlag

Publisher-Information
Bone Marrow Transplant. 2010 Oct;45(10):1489-96.

Link

Zur Publikation (externer Server)

Tags

Forschungsthemen
MS Behandlung